Literature DB >> 26589223

The Epinephrine/Norepinephrine/Autoinducer-3 Interkingdom Signaling System in Escherichia coli O157:H7.

Cristiano G Moreira1, Vanessa Sperandio2.   

Abstract

Epinephrine/norepinephrine/AI-3 signaling is used as an interkingdom chemical signaling system between microbes and their hosts. This system is also exploited by pathogens to regulate virulence traits. In enterohemorrhagic E. coli (EHEC) O157:H7, it is essential for pathogenesis and flagella motility. These three signals activate expression of a pathogenicity island named locus of enterocyte effacement (LEE), Shiga toxin, and the flagella regulon. These signals are sensed by the two-component system QseBC, whereas the bacterial membrane receptor QseC autophosphorylates and phosphorylates the QseB response regulator initiating a complex phosphorelay signaling cascade that activates the expression of a second two-component system, QseEF. The QseEF two-component system is also involved in the expression of the virulence genes, and it senses epinephrine, phosphate, and sulfate. This complex signaling cascade still needs to be completely elucidated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26589223     DOI: 10.1007/978-3-319-20215-0_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  17 in total

Review 1.  Involvement of Two-Component Signaling on Bacterial Motility and Biofilm Development.

Authors:  Birgit M Prüß
Journal:  J Bacteriol       Date:  2017-08-22       Impact factor: 3.490

2.  Identification of the Hypertension Drug Guanfacine as an Antivirulence Agent in Pseudomonas aeruginosa.

Authors:  Bethany K Okada; Anran Li; Mohammad R Seyedsayamdost
Journal:  Chembiochem       Date:  2019-07-03       Impact factor: 3.164

Review 3.  Bacterial cross talk with gut microbiome and its implications: a short review.

Authors:  Rajesh P Shastry; P D Rekha
Journal:  Folia Microbiol (Praha)       Date:  2020-09-19       Impact factor: 2.099

Review 4.  Strategies for Biofilm Inhibition and Virulence Attenuation of Foodborne Pathogen-Escherichia coli O157:H7.

Authors:  Sandra Folarin Oloketuyi; Fazlurrahman Khan
Journal:  Curr Microbiol       Date:  2017-07-25       Impact factor: 2.188

5.  Variation in spatial organization of the gut microbiota along the longitudinal and transverse axes of the intestines.

Authors:  Edward Fox; Mark Lyte
Journal:  Arch Microbiol       Date:  2022-06-24       Impact factor: 2.552

6.  Bioactive small molecules produced by the human gut microbiome modulate Vibrio cholerae sessile and planktonic lifestyles.

Authors:  Heidi Pauer; Felipe Lopes Teixeira; Avery V Robinson; Thiago E Parente; Marília A F De Melo; Leandro A Lobo; Regina M C P Domingues; Emma Allen-Vercoe; Rosana B R Ferreira; Luis Caetano M Antunes
Journal:  Gut Microbes       Date:  2021 Jan-Dec

7.  Insights into Adaptive Mechanisms of Extreme Acidophiles Based on Quorum Sensing/Quenching-Related Proteins.

Authors:  Shanshan Huang; Xueduan Liu; Weiyi Yang; Liyuan Ma; Huiying Li; Rui Liu; Jingxuan Qiu; Yiran Li
Journal:  mSystems       Date:  2022-04-11       Impact factor: 7.324

Review 8.  Diarrheagenic Escherichia coli.

Authors:  Tânia A T Gomes; Waldir P Elias; Isabel C A Scaletsky; Beatriz E C Guth; Juliana F Rodrigues; Roxane M F Piazza; Luís C S Ferreira; Marina B Martinez
Journal:  Braz J Microbiol       Date:  2016-11-05       Impact factor: 2.476

9.  Overexpressed Proteins in Hypervirulent Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 Compared to E. coli O157:H7 EDL933 Clade 3 Strain.

Authors:  Natalia Amigo; Qi Zhang; Ariel Amadio; Qunjie Zhang; Wanderson M Silva; Baiyuan Cui; Zhongjian Chen; Mariano Larzabal; Jinlong Bei; Angel Cataldi
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

10.  Highly Effective Inhibition of Biofilm Formation by the First Metagenome-Derived AI-2 Quenching Enzyme.

Authors:  Nancy Weiland-Bräuer; Martin J Kisch; Nicole Pinnow; Andreas Liese; Ruth A Schmitz
Journal:  Front Microbiol       Date:  2016-07-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.